Jiangxi Rimag Group Future Growth
Future criteria checks 5/6
Jiangxi Rimag Group is forecast to grow earnings and revenue by 71.8% and 30% per annum respectively. EPS is expected to grow by 71.4% per annum. Return on equity is forecast to be 9.7% in 3 years.
Key information
71.8%
Earnings growth rate
71.4%
EPS growth rate
| Healthcare earnings growth | 19.6% |
| Revenue growth rate | 30.0% |
| Future return on equity | 9.7% |
| Analyst coverage | Low |
| Last updated | 12 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,743 | 198 | -61 | 222 | 1 |
| 12/31/2025 | 1,337 | 131 | -113 | 164 | 1 |
| 12/31/2024 | 1,004 | 73 | 46 | 196 | 1 |
| 6/30/2024 | 813 | 5 | -85 | 138 | N/A |
| 3/31/2024 | 871 | 25 | 10 | 170 | N/A |
| 12/31/2023 | 929 | 44 | 105 | 201 | N/A |
| 12/31/2022 | 784 | 0 | -73 | 198 | N/A |
| 12/31/2021 | 592 | -361 | -125 | 18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2522's forecast earnings growth (71.8% per year) is above the savings rate (2.3%).
Earnings vs Market: 2522's earnings (71.8% per year) are forecast to grow faster than the Hong Kong market (11.8% per year).
High Growth Earnings: 2522's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2522's revenue (30% per year) is forecast to grow faster than the Hong Kong market (7.3% per year).
High Growth Revenue: 2522's revenue (30% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2522's Return on Equity is forecast to be low in 3 years time (9.7%).